New Approach Developed to Improve Drug Delivery in Tumors

Jul 19, 2010 By Rebecca Ruiz-McGill
Simulated images of microvessel networks

( -- By using mathematical modeling to understand blood flow, researchers -- including the UA's Timothy Secomb, a pioneer in the field -- have proposed a novel approach to treating cancerous tumors.

Researchers know that blood vessels are poor at transporting and cancer-fighting drugs in tumors. Using mathematical modeling, scientists have found a new approach that may improve in the tumor and increase its effectiveness.

Timothy Secomb of the University of Arizona and his colleagues discovered that impaired communication in tumor microvascular networks can lead to the shunting of blood away from some regions of the tumor.

Treatments that inhibit the growth of new vessels, they argue, may help restore communication and improve flow and distribution in tumor blood vessels.

"We know the blood supply in the tumors is abnormal, and we've asked, ‘What's different about it?'" Secomb said. "By improving circulation - getting the vasculature working again - there is a better chance of getting drugs to the tumor."

Secomb collaborated on this work with Axel Pries of Charité in Berlin, Germany, and Mark Dewhirst of Duke University Medical Center. The results were published in the latest online edition of Nature Reviews Cancer.

Secomb is a pioneer in applying mathematical approaches to understanding how blood flows in the smallest branches of the circulatory system. He is a professor in the UA departments of physiology and mathematics and is a member of Arizona Research Laboratories, BIO5 and the Arizona Cancer Center.

In detail, the researchers examined communication along vessel walls, which is needed to coordinate the distribution of . Gap junctions connect the endothelial cells of the vessels. The researchers theorize that the gap junctions do not exist or don't work well in tumors, which lead to loss of communication. The vessel structure in the tumor reflects this breakdown of communication.

Long pathways and shortcuts exist from arteries to the veins. The researchers predicted that, in tumors, the shortcuts tend to grow in diameter, shunting the flow away from the long pathways.

One line of attack is to give a VEGF (vascular endothelial growth factor) antagonist to improve communication and reduce shunting, which enables better delivery of anti-tumor therapies.

The researchers say that approaches targeted at improving gap junction communication may be able to take advantage of this concept in a more predictable manner.

Explore further: Discovery of new genomic aberrations of gastric cancer could pave the way for precision medicine

More information:

Related Stories

'Normalizing' tumor vessels leaves cancer more benign

Feb 12, 2009

A report publishing online on February 12th in the journal Cell, a Cell Press publication, suggests a counterintuitive new method to make cancer less likely to spread: by normalizing the shape of tumors' blood vessels to ...

Precancerous stem cells can form tumor blood vessels

Feb 20, 2008

Tumors require a blood supply to grow, but how they acquire their network of blood vessels is poorly understood. A new study here shows that tumor blood vessels can develop from precancerous stem cells, a recently discovered ...

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.